Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Inflammatory Bowel Diseases|April 10, 2015
G Protein-coupled pH-sensing Receptor OGR1 Is a Regulator of Intestinal InflammationCheryl de Vallière, Yu Wang, Jyrki J Eloranta, et al.
Journal of Lipid Research|May 23, 2019
Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitisTina Raselli, Tom Hearn, Annika Wyss, et al.
Mucosal Immunology|February 12, 2019
The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitisAnnika Wyss, Tina Raselli, Nathan Perkins, et al.
The Journal of Clinical Investigation|October 1, 2020
Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer developmentEgle Katkeviciute, Larissa Hering, Ana Montalban-Arques, et al.
The Journal of Clinical Investigation|April 5, 2016
NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22Marianne R Spalinger, Stephanie Kasper, Claudia Gottier, et al.
Gut|October 3, 2022
TiO2 nanoparticles abrogate the protective effect of the Crohn's disease-associated variation within the PTPN22 gene locusMarlene Schwarzfischer, Anna Niechcial, Kristina Handler, et al.
The Journal of Clinical Investigation|October 8, 2021
T cell protein tyrosine phosphatase protects intestinal barrier function by restricting epithelial tight junction remodelingRonald R Marchelletta, Moorthy Krishnan, Marianne R Spalinger, et al.
International Journal of Cancer|January 18, 2019
β6 -integrin serves as a novel serum tumor marker for colorectal carcinomaSusan Bengs, Eugenia Becker, Philipp Busenhart, et al.
Nature Communications|April 20, 2026
Indirect inhibition of the NLRP3-interleukin-1β axis contributes to the efficacy of JAK1 inhibitors in experimental colitis and human ulcerative colitisBeibei Liu, Marianne R Spalinger, Annalisa Invernizzi, et al.
Cell Host & Microbe|August 28, 2021
Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumorsAna Montalban-Arques, Egle Katkeviciute, Philipp Busenhart, et al.
Pageof 8